Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Adrenergic receptor inhibitor
BML-ST405-0005 5 g 61.00 USD
Do you need bulk/larger quantities?
Propranolol blocks PLD derived DAG formation by inhibiting phosphatidate phosphohydrolase (IC50=70 µM). It is a useful tool to discriminate between PLC or PLD mediated DAG production. It is also a β-adrenergic receptor blocking agent.

Product Specification

Formula:C16H21NO2 . HCl
Purity:≥98% (HPLC)
Identity:Determined by 1H-NMR and LC-MS.
Appearance:White to off-white powder.
Solubility:Soluble in water.
Long Term Storage:-20°C
ST405 Propranolol
Please mouse over
ST405 Propranolol

Product Literature References

New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators: X. Sun, et al.; Cell Cycle 14, 721 (2015), Abstract; Full Text
Receptor-coupled phospholipase D and its inhibition: N.T. Thompson, et al.; Trends Pharmacol. Sci. 12, 404 (1991), Abstract;
Regulation of phospholipase D in HL-60 granulocytes. Activation by phorbol esters, diglyceride, and calcium ionophore via protein kinase- independent mechanisms: M. M. Billah, et al.; J. Biol. Chem. 264, 9069 (1989), Abstract; Full Text
The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias: A. M. Barrett, et al.; Br. J. Pharmacol. 34, 43 (1968), Abstract; Full Text

Related Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,